How to manage a 65-year-old female with iron overload, polycythemia, hypertension, hyperlipidemia, and chronic fatigue?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Iron Overload with Polycythemia in a 65-Year-Old Female

Therapeutic phlebotomy is the recommended first-line treatment for this patient with elevated ferritin (243 ng/mL) and polycythemia (Hgb 16.3, Hct 48.5, RBC 5.5) to reduce iron stores and improve symptoms of chronic fatigue.

Assessment of Iron Status and Polycythemia

  • The patient's ferritin level of 243 ng/mL indicates mild iron overload, though it is below the threshold that would typically trigger aggressive intervention (>500-1000 ng/mL) 1
  • The elevated hemoglobin (16.3), hematocrit (48.5), and RBC count (5.5) indicate polycythemia, which can contribute to hyperviscosity and associated complications 2
  • Chronic fatigue in this patient may be related to both iron overload and polycythemia, as both conditions can negatively impact quality of life 3, 4
  • The combination of iron overload with polycythemia requires careful management to address both conditions simultaneously 2

Treatment Approach

Phlebotomy Protocol

  • Initiate therapeutic phlebotomy with removal of 450-500 mL of blood weekly or biweekly until ferritin levels decrease to 50 ng/mL or less 1
  • Monitor hematocrit prior to each phlebotomy session; avoid allowing hematocrit to fall by more than 20% of prior level during any single session 1, 2
  • Check serum ferritin level every 10-12 phlebotomies to track progress 1
  • Once target ferritin level is achieved, transition to maintenance phlebotomy (typically 3-4 times per year for men, 1-2 times for women) 1
  • Adjust frequency of maintenance phlebotomy based on periodic monitoring of ferritin, hemoglobin, and hematocrit 1

Monitoring Protocol

  • Monitor serum ferritin, hemoglobin, and hematocrit regularly during treatment 1
  • Assess for improvement in symptoms, particularly chronic fatigue 5, 3
  • Monitor for potential complications related to both iron overload and polycythemia 3, 4
  • Consider periodic assessment of organ function, particularly cardiac and hepatic, if iron overload is significant 1, 3

Dietary and Lifestyle Modifications

  • Avoid vitamin C supplements, which can enhance iron absorption and potentially worsen iron overload 1, 5
  • Minimize alcohol consumption, which increases iron absorption 1
  • Avoid iron-containing multivitamins and supplements 1, 5
  • Consider reducing consumption of highly iron-rich foods such as red meat, though dietary restrictions alone have minimal impact on total body iron 1

Management of Comorbidities

  • Continue appropriate management of hypertension and hyperlipidemia, as these conditions can worsen cardiovascular risks when combined with iron overload 3
  • Address chronic fatigue through both iron reduction therapy and management of underlying conditions 5, 3
  • Monitor for development of diabetes, as iron overload increases this risk, especially in patients with other metabolic risk factors 3, 4

Special Considerations and Pitfalls

  • Avoid excessive phlebotomy, which could lead to anemia and worsen fatigue symptoms 1, 2
  • Do not delay treatment, as early intervention prevents complications of iron overload including organ damage 5, 4
  • Consider genetic testing for hereditary hemochromatosis if ferritin levels remain elevated despite therapy or if there is a family history of iron overload 1, 5
  • Be aware that ferritin is an acute phase reactant; inflammatory conditions may falsely elevate levels, so interpret in context of clinical picture 1, 6
  • Consider additional workup for secondary causes of polycythemia if phlebotomy does not adequately control hematocrit levels 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effects of iron overload on chronic metabolic diseases.

The lancet. Diabetes & endocrinology, 2014

Research

Chronic iron overload and toxicity: clinical chemistry perspective.

Clinical laboratory science : journal of the American Society for Medical Technology, 2001

Research

Iron overload syndromes.

Clinical physiology and biochemistry, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.